Testosterone therapy may be a reasonable and cost-effective alternative to estradiol for some women, particularly for treating Hypoactive Sexual Desire Disorder (HSDD).

“I I the data I just have it in front of me is that it was there were 46 studies um looking at 36 that of the trials were randomized and like 8,500 women close to 8500 women so there were lot there's lots of data it's not lacking right there there there's a like probably even more that didn't get into the man analysis because it didn't meet the criteria we have lots of data it's not based on lack of data”

“there have been a number of randomized control trials looking at similar doses um mostly in patches looking at women on and off estrogen free and postmenopausal Surgical and natural menopause um that have shown the SE efficacy with the outcome of hsd hyperoptic sexual desire um being the the primary outcome and showing other parameters with Improvement like arousal orgasm satisfaction Etc and the same based on that consensus papers that have come out in the last couple years really say that this is indicated and solely for late repr probably late reproductive age there's two different guidances and definitely postmenopausal women based on this efficacy and safety data and these numbers of randomized Trials and this large Med analysis that looked at efficacy and safety of numerous studies demonstrates this”

“But the the consensus is it works, but everyone has emotions about testosterone. I don't know. I didn't think testosterone was a feeling, but apparently it is a feeling for people because people hate talking about it.”

“But the the consensus is it works, but everyone has emotions about testosterone. I don't know. I didn't think testosterone was a feeling, but apparently it is a feeling for people because people hate talking about it.”